作者：
Gibson,P.R. [1]
;
Vaizey,C. [2]
;
Black,C.M. [3]
;
Nicholls,R. [4]
;
Weston,A.R. [5]
;
Bampton,P. [6]
;
Sparrow,M. [7]
;
Lawrance,I.C. [8]
;
Selby,W.S. [9]
;
Andrews,J.M. [10]
;
Walsh,A.J. [11]
;
Hetzel,D.J. [12]
;
Macrae,F.A. [13]
;
Moore,G.T. [14]
;
Weltman,M.D. [15]
;
Leong,R.W. [16]
;
Fan,T.
作者单位：
St. Mark's Hospital, London, United Kingdom, Nepean Hospital, University of Sydney, Sydney, NSW
[1]
Alfred Hospital, Australia
[2]
Centre for Inflammatory Bowel Diseases, School of Medicine and Pharmacology, University of Western
[3]
University of Sydney, Sydney, NSW, Australia
[4]
Flinders Private Hospital, Bedford Park, Southern Australia, Australia
[5]
Royal Melbourne Hospital, Parkville, VIC, Australia
[6]
University of Sydney, Sydney, NSW, Australia, Monash Medical Centre, Clayton, VIC, Australia
[7]
East Adelaide Medical Centre, Adelaide, SA, Australia
[8]
St. John's University, Queens, NY, United States
[9]
Monash University, Clayton, VIC, Australia
[10]
Nepean Hospital, University of Sydney, Sydney, NSW, Australia
[11]
Merck Sharp and Dohme Corp., Whitehouse Station, NJ, United States, OptumInsight, Sydney, NSW
[12]
IBD Service, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, SA
[13]
School of Medicine, University of Adelaide, Adelaide, SA, Australia, St. Vincent's Hospital, Sydney
[14]
Royal Prince Alfred Hospital, Camperdown, NSW, Australia
[15]
Alfred Hospital, Australia, Monash Medical Centre, Clayton, VIC, Australia
[16]
发布时间
2014-09-19
换一批
